NSC |
Compound |
Enrichment |
Correlation |
NSC 166237 |
Ethanol, 2,2'-[[3-methyl-4-[[[4-(2-methyl-4-thiazolyl)phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester), monohydrochloride (9CI) |
0.000260156221906648 |
0.63306526 |
NSC 240529 |
2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- |
0.000260156221906648 |
0.78916299 |
NSC 275656 |
m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- |
0.000260156221906648 |
0.93437474 |
NSC 659949 |
14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone |
0.000260156221906648 |
0.70768327 |
NSC 724994 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.000260156221906648 |
0.75093967 |
NSC 725775 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.000260156221906648 |
0.64452818 |
NSC 735037 |
Camptothecin Derivative |
0.000260156221906648 |
0.84786844 |
NSC 102627 |
Yoshi 864 |
0.000272379738694984 |
0.92289976 |
NSC 677169 |
Null |
0.000272379738694984 |
0.55704129 |
NSC 680420 |
Null |
0.000272379738694984 |
0.60407856 |